Search

Search Results

Found 51 items.

Effects of the availability of new oral anticoagulants in patients with non-valvular atrial fibrillation in the real world: the NAIF study

Francesco Ventrella, Franco Mastroianni, Sergio Cappello, Luigi Iamele, Samantha Errico, Massimo Errico

176-183

06-07-2016

1417

PDF: 900

HTML: 341
Assessment and predictors of inappropriate dose of direct oral anticoagulants

Mosaad O. Almegren

09-01-2024

722

pdf: 347

HTML: 113
Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation

Tommaso Sacquegna, Anna Zaniboni, Andrea Rubboli, Gaetano Procaccianti, Michela Crisci, Fabiola Maioli, Giorgia Arnone, Giuseppe Di Pasquale

314-322

15-12-2015

1914

PDF: 881

HTML: 1227
Sex-gender and atrial fibrillation treatment in the AntiThrombotic Agents in Atrial Fibrillation (ATA-AF) study

Cecilia Politi, Tiziana Ciarambino, Letizia Riva, Stefania Frasson, Donata Lucci, Gualberto Gussoni, Lucio Gonzini, Mauro Campanini, Michele Gulizia, Giuseppe Di Pasquale, Giovanni Mathieu, on behalf of ATA-AF Steering Committee and Investigators

207-212

16-02-2016

1631

PDF: 1429

Appendix: 654

HTML: 544
Emergency management of patients being treated with oral anticoagulants

Franco Manzato, Massimo Franchini

234-241

17-12-2013

1039

PDF: 819

HTML: 302
The practical management of bleedings during treatment with direct oral anticoagulants: the emergency reversal therapy

Luca Masotti, Giancarlo Landini, Grazia Panigada

48-58

24-12-2013

1322

PDF: 900
Stroke prevention in atrial fibrillation: findings from Tuscan FADOI Stroke Registry

Luca Masotti, Rinaldo Innocenti, Stefano Spolveri, Irene Chiti, Grazia Panigada, Cristiana Seravalle, Giancarlo Landini, Alberto Fortini, Rino Migliacci, Raffaele Laureano, for Tuscan FADOI Stroke Registry Investigators

134-140

12-06-2014

1517

PDF: 1187

Appendix: 563

HTML: 622
Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics

Luca Masotti, Mauro Campanini

1-7

24-12-2013

9498

PDF: 2677
Direct oral anticoagulants in real practice: which doses for which patients. Limitations and bleeding risk compared to vitamin K antagonists

Giancarlo Landini, Luca Masotti

41-47

24-12-2013

881

PDF: 773
The treatment of venous thromboembolism with new oral anticoagulants

Davide Imberti

29-35

24-12-2013

1033

PDF: 811
Vorapaxar

Gianluca Airoldi, Mauro Campanini

88-95

24-04-2013

1124

PDF: 619

HTML: 219
Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation

Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Cecilia Becattini, Maurizio Paciaroni, Daniel Augustin Godoy, Roberto Cappelli, Giancarlo Landini, Grazia Panigada, Ido Iori, Domenico Prisco, Giancarlo Agnelli

8-21

24-12-2013

1271

PDF: 835
A review on management of antiphospholipid syndrome in clinical practice

Carmine Siniscalchi, Pietro Rossetti, Gaetano Carolla, Pierpaolo Di Micco, Adriano Stella, Michele Riva

13-09-2023

2149

PDF: 901

HTML: 53
Monitoring strategies for patients treated with the new oral anticoagulants and the need for laboratory evaluation of hemostasis

Andrea Fontanella, Pierpaolo Di Micco

59-64

24-12-2013

903

PDF: 881
New oral anticoagulants: key messages for clinicians

Matteo Giorgi-Pierfranceschi, Chiara Cattabiani, Francesco Dentali

74-84

24-12-2013

1236

PDF: 844
Apixaban

Gianluca Airoldi, Mauro Campanini

128-134

07-03-2013

1106

PDF: 1760
Cryptogenic stroke

Michele Stornello, Roberto Cappellani, Giuseppe Micieli, Simona Sacco, Stefano Spolveri, Roberto Sterzi, Danilo Toni, Antonio Carolei

185-194

30-09-2016

1830

PDF: 1070

HTML: 581
Newer non-vitamin K-antagonist direct oral anticoagulants in acute coronary syndromes

Andrea Rubboli

22-28

24-12-2013

952

PDF: 714
Pregnancy and heart disease: what Internists should know

Riccardo Gerloni, Domenico Panuccio

288-304

11-09-2017

1264

PDF: 638

HTML: 263
Characteristics and clinical management of acute pulmonary embolism in real world: findings from TUSCAN-PE study

Luca Masotti, Filippo Pieralli, Grazia Panigada, Francesco Corradi, Rino Migliacci, Salvatore Lenti, Alessandro Tafi, Carlo Nozzoli, Giancarlo Landini, for TUSCAN-PE Investigators

125-133

03-06-2014

2055

PDF: 1250

Appendix: 1081

HTML: 747
Efficacy and safety of new oral anticoagulants compared with warfarin in cardioembolic prophylaxis of patients with non valvular atrial fibrillation. More lights than shadows

Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Daniel Godoy, Grazia Panigada, NiccolÃ² Napoli, Giancarlo Landini, Roberto Cappelli, Ido Iori, Domenico Prisco, Giancarlo Agnelli

153-169

23-10-2012

1625

PDF: 1924
Clinical characteristics of very old patients hospitalized in internal medicine wards for heart failure: a sub-analysis of the FADOI-CONFINE Study Group

Paolo Biagi, Roberto Nardi, Concetta Isabella Baldo, Giovanni Scanelli, Domenico Panuccio, Andrea Bonanome, Fabio Miserocchi, Luigi Lusiani, Erminio Bonizzoni, Mauro Campanini, Carlo Nozzoli, Giorgio Vescovo, on behalf of the FADOI-CONFINE Study Group

19-28

17-03-2014

1833

PDF: 1068

HTML: 657
How to manage new oral anticoagulants in case of surgery

Davide Imberti

36-40

24-12-2013

876

PDF: 798
Clinical management of spontaneous intracranial haemorrhage associated with oral anticoagulants: a case series

Luca Masotti, Alessandro Pampana, Paolo Pennati, Giancarlo Landini

34-44

07-03-2013

723

PDF: 983
Results of prospective multicenter study on heart failure on Campania Internal Medicine wards: the FASHION study

Fernando Gallucci, Ilaria Ronga, Andrea Fontanella, Generoso Uomo, and the FASHION Study Group

184-190

14-06-2017

1283

PDF: 710

HTML: 450
Portal vein thrombosis and Budd-Chiari syndrome as onset of polycythemia vera

Aurelio Seidita, Delia Sprini, Accursia BongiovÃ¬, Tiziana Catalano, Filippo Barbiera, Maria Accardi, Pasquale Mansueto, Antonio Carroccio

196-205

19-09-2013

1813

PDF: 1034

HTML: 1868
Sex differences in adverse drug reaction and liver disease

Ombretta Para, Pietro Crispino, Nunzia Barone, Sara Macis, Laura Airasca, Paola Gnerre, Cecilia Politi

15-22

20-03-2018

1932

PDF: 823

HTML: 441
Thrombophilias: therapeutic employment of direct oral anticoagulants in venous hypercoagulable states

Federico Cacciapuoti

136-142

17-09-2020

723

PDF: 477

HTML: 293
Patent foramen ovale and ischemic stroke: more shadows than lights? What the internist should know

Andrea Donti

175-184

30-09-2016

1549

PDF: 876

HTML: 923
Pharmacological interactions in novel oral anticoagulants, statins, and hypertension drugs in patients treated with direct-acting antivirals for hepatitis C: a Delphi Consensus project

Ivan Gentile, Giancarlo Agnelli, Angelo Avogaro, Claudio Borghi, Alessia Ciancio, Ernesto Claar, Patrizio Pasqualetti, Pasquale Perrone Filardi

25-11-2024

11

PDF: 3

SUPPLEMENTARY MATERIAL: 1

ACKNOWLEDGMENTS: 2
Management of major bleeding in patients treated with direct oral anticoagulants: from experience to standardized protocols

Sara Mascia, Anna Maria Ferrari, Nicola Macarone Palmieri, Elisa Romagnoli, Chiara Catena, Serena Scarabottini, Francesca Mori, Lucio Brugioni

43-48

17-06-2020

872

PDF: 584

HTML: 143
Embolic stroke of undetermined source: a retrospective analysis from an Italian Stroke Unit

Marco Masina, Annalena Cicognani, Carla Lofiego, Simona Malservisi, Riccardo Parlangeli, Alessandro Lombardi

202-206

30-09-2016

1557

PDF: 802

HTML: 803
A dangerous adverse event in the use of dabigatran

Manuel Monti, Giovanni Maria Vincentelli, Francesco Borgognoni, Giuseppe Murdolo, Feliciano Menghini

250-251

09-11-2015

1556

PDF: 862

HTML: 253
Treatment and secondary prophylaxis of venous thromboembolism with direct oral anticoagulants in patients with severe hereditary thrombophilia

Pasquale Madonna, Anna Guida, Maria Gabriella Coppola, Paolo Tirelli, Ernesto Grasso

18-03-2021

1017

PDF: 499

HTML: 51
The heart failure in Internal Medicine in Tuscany: the SMIT Study

Valerio Verdiani, Grazia Panigada, Alberto Fortini, Luca Masotti, Simone Meini, Paolo Biagi, for the SMIT Study Group

349-355

15-12-2015

1546

PDF: 818

Appendix: 992

HTML: 748
Differences in in-hospital clinical course, management and outcome between stroke with and without atrial fibrillation. A retrospective analysis from the SETI (Studio Epidemiologico Toscano Ictus) study

P. Biagi, S. Bocchini, R. Laureano, G. Panigada, G. Vescovo

14-22

03-05-2013

958

PDF: 741
Gender medicine: an up-date

Cecilia Politi, Tiziana Ciarambino, Flavia Franconi, Lucrezia De Feudis, Maria Carolina Mayer, Alessandra Martignoni, Ilaria Giovi, Michela Tonani, Salvatore La Carrubba, Anna Maria Moretti, Carmen Martino, Giovanni Scanelli

96-106

24-04-2013

2015

PDF: 865

HTML: 468
Acute severe renal failure in a patient receiving apixaban: a case report

Attilia Maria Pizzini, Chiara Fantoni, Stefania Zaccaroni, Mauro Silingardi

09-04-2024

425

PDF: 326

HTML: 67
The FADOI (Federation of Associations of Hospital Doctors on Internal Medicine) position paper on cardiovascular prevention in the higher risk complex patients

Mauro Campanini, Giuliano Pinna, Roberto Nardi, on behalf of the FADOI Cardiovascular Prevention Position Statements Group

387-404

15-12-2015

1967

PDF: 847

Appendix: 454

HTML: 1459
The management of the patient with acute pancreatitis: from evidence to clinical practice

Cristina Cenci, Tea Restuccia, Paola Gnerre, Irene Chiti, Laura Betti, Milena Micati, Claudio Tana

220-245

11-09-2017

2600

PDF: 1148

HTML: 1321
Anticoagulation in the early phase of non-valvular atrial fibrillation-related acute ischemic stroke: where do we stand?

Luca Masotti, Elisa Grifoni, Alessandro Dei, Vieri Vannucchi, Federico Moroni, Grazia Panigada, Stefano Spolveri, Giancarlo Landini

24-31

03-01-2019

1325

PDF: 732

HTML: 71
Generic - equivalent drugs use in internal and general medicine patients: distrust, confusion, lack of certainties or of knowledge? Part 3. Clinical issues

Roberto Nardi, Marco Masina, Giorgio Cioni, Paolo Leandri, Paola Zuccheri

99-109

08-05-2014

2163

PDF: 1340

HTML: 716
Abdominal pain: a synthesis of recommendations for its correct management

Daniela Tirotta, Annalisa Marchetti, Mariangela Di Lillo, Fulvio Pomero, Roberta Re, Michele Meschi, Domenico Montemurro, Paola Gnerre, Chiara Bozzano, Micaela La Regina

193-202

08-05-2015

3689

PDF: 1369

Appendix: 529

HTML: 8936
Optimal duration of anticoagulant therapy in patients with venous thromboembolism

Gualtiero Palareti

235-244

14-09-2018

1429

PDF: 1731

HTML: 257
Equivalent/generic drugs use. To whom? When? How?

Andrea Fontanella

77-79

08-05-2014

1006

PDF: 752

HTML: 236
The management of heart failure: a FADOI survey in the setting of Internal Medicine Units

Fernando Gallucci

16-02-2023

1655

PDF: 486

HTML: 13
How artificial intelligence during the pandemic modified the role of a biomarker as d-dimer

Pierpaolo Di Micco, Francesca Futura Bernardi, Giovanni Maria Fusco, Alessandro Perrella

20-11-2023

810

PDF: 252

HTML: 28
An unusual cause of massive hemoptysis

Silvia Maestroni, Martino Cellerini, Antonio Brucato

71-74

01-07-2016

1282

PDF: 820

HTML: 378
The management of the patient with non-variceal upper gastrointestinal bleeding: from evidence to clinical practice

Maddalena Zippi, Mariella Frualdo, Luciano Mucci, Marta Zanon, Chiara Marzano, Claudio Cassieri, Paola Gnerre, Pietro Crispino

246-252

27-12-2016

1372

PDF: 911

HTML: 280
Management of chronic obstructive pulmonary disease: criteria for an appropriate hospital discharge

Marco Candela, Ruggero Pastorelli, Antonio Sacchetta, Mauro Campanini, Leonardo M. Fabbri, Carlo Nozzoli

218-230

19-09-2013

1382

PDF: 1012

HTML: 854

1 - 50 of 51 items 1 2 > >>

© PAGEPress 2008-2024 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy